⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL557960 | 0.97 | — | — | |
| SCHEMBL3459429 | 0.91 | — | — | |
| SCHEMBL10354611 | 0.88 | — | — | |
| SCHEMBL3471566 | 0.88 | — | — | |
| SCHEMBL3459548 | 0.87 | — | — | |
| SCHEMBL3459017 | 0.85 | — | — | |
| SCHEMBL2687665 | 0.84 | — | — | |
| SCHEMBL10354646 | 0.84 | — | — | |
| SCHEMBL11105757 | 0.80 | — | — | |
| SCHEMBL3869487 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381232-A1 | BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS | TETROUS INC (US) | 2025-12-18 | — | — | US | claimed |
| US-12419916-B2 | Bone derived fibers and oxygenated wound treatments | TETROUS, INC. (US) | 2025-09-23 | — | — | US | claimed |
| EP-4520312-A2 | THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION | Tetrous, Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| EP-3664770-B1 | THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION | TETROUS INC (US) | 2024-12-04 | — | — | EP | claimed |
| CN-111356432-B | Cosmetic product for therapeutic gas infusion and method of infusion | 特劳斯公司 | 2024-05-31 | — | — | CN | claimed |
| US-20230355682-A1 | BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS | TETROUS, INC. | 2023-11-09 | — | — | US | claimed |
| US-11622979-B2 | Bone derived fibers and oxygenated wound treatments | TETROUS, INC. (US) | 2023-04-11 | — | — | US | claimed |
| US-20220040237-A1 | OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH | ISTO TECHNOLOGIES II, LLC | 2022-02-10 | — | — | US | claimed |
| CN-113956851-A | Compositions comprising fluoroolefins | 科慕埃弗西有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113943552-A | Compositions comprising fluoroolefins | 科慕埃弗西有限公司 | 2022-01-18 | — | — | CN | claimed |
| US-4803842-A | MINIMIZES MIGRATION OF TOXINS | CASTLETON, INC. (US) | 1989-02-14 | — | — | US | claimed |
| EP-0281232-A1 | Direct contact cooling and freezing of articles with halocarbon heat transfer liquids | CASTLETON, INC. (US) | 1988-09-07 | — | — | EP | claimed |
| US-4730460-A | FREONS | CASTLETON, INC. (US) | 1988-03-15 | — | — | US | claimed |
| EP-0231091-A1 | Stable emulsions of highly fluorinated organic compound | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1987-08-05 | — | — | EP | claimed |
| US-4586511-A | Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1986-05-06 | — | — | US | claimed |
| US-4558279-A | Methods for detecting and imaging a temperature of an object by nuclear magnetic resonance | UNIVERSITY OF CINCINNATI (US) | 1985-12-10 | — | — | US | claimed |
| EP-0033402-B1 | PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD | The Green Cross Corporation (JP) | 1983-09-07 | — | — | EP | claimed |
| EP-0033402-A1 | Perfusate for preserving organ to be transplanted and preserving method | The Green Cross Corporation (JP) | 1981-08-12 | — | — | EP | claimed |
| US-4186253-A | RINGER'S SOLUTION WITH INCREASED POTASSIUM ION, ALBUMIN, PERFLUOROCARBON COMPOUND, EMULSIFIER | THE GREEN CROSS CORPORATION (JP) | 1980-01-29 | — | — | US | claimed |
| US-3962439-A | PERFLUOROCARBON COMPOUNDS | THE GREEN CROSS CORPORATION (JA) | 1976-06-08 | — | — | US | claimed |